Moreover, supporting mitochondrial-dependent apoptosis cascade activation, robust caspase-3 and caspase-9 activation in SKI-178-treated prostate cancer cells was detected (Fig. 3). This evidence concerns the gene CASP9 and Familial prostate cancer.